Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bock

Showing results (141-150 of 202) with videos related to

Pageof 21
Sort By:
Current Biology : CB|December 24, 2013
The availability of research data declines rapidly with article ageTimothy H Vines, Arianne Y K Albert, Rose L Andrew, et al.
European Journal of Pharmacology|November 29, 2005
Inhibition of acute nociceptive responses in rat spinal cord by a bradykinin B1 receptor antagonistRachel K Conley, Alan Wheeldon, Janine K Webb, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonistsR M DiPardo, M A Patane, R C Newton, et al.
Bioorganic & Medicinal Chemistry|September 1, 1994
Selective non-peptide ligands for an accommodating peptide receptor. Imidazobenzodiazepines as potent cholecystokinin type B receptor antagonistsM G Bock, R M DiPardo, R C Newton, et al.
Biochemical Society Transactions|December 1, 1984
Renin inhibitors containing 2-substituted statineD F Veber, M G Bock, S F Brady, et al.
Journal of Medicinal Chemistry|March 18, 1994
Second-generation benzodiazepine CCK-B antagonists. Development of subnanomolar analogs with selectivity and water solubilityM G Bock, R M DiPardo, E C Mellin, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1991
Antagonism of oxytocin in rats and pregnant rhesus monkeys by the novel cyclic hexapeptides, L-366,682 and L-366,948B V Clineschmidt, D J Pettibone, D R Reiss, et al.
Journal of Medicinal Chemistry|October 16, 1992
Development of a novel class of cyclic hexapeptide oxytocin antagonists based on a natural productP D Williams, M G Bock, R D Tung, et al.
Journal of Medicinal Chemistry|July 1, 1987
Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonistsB E Evans, K E Rittle, M G Bock, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 22, 2024
Target Cell Activation of a Structurally Novel NOD-Like Receptor Pyrin Domain-Containing Protein 3 Inhibitor NT-0796 Enhances PotencyPamela Smolak, MyTrang Nguyen, Christine Diamond, et al.
Pageof 21

Showing results (141-150 of 202) with videos related to

Sort By:
Pageof 21
Current Biology : CB|December 24, 2013
The availability of research data declines rapidly with article ageTimothy H Vines, Arianne Y K Albert, Rose L Andrew, et al.
European Journal of Pharmacology|November 29, 2005
Inhibition of acute nociceptive responses in rat spinal cord by a bradykinin B1 receptor antagonistRachel K Conley, Alan Wheeldon, Janine K Webb, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonistsR M DiPardo, M A Patane, R C Newton, et al.
Bioorganic & Medicinal Chemistry|September 1, 1994
Selective non-peptide ligands for an accommodating peptide receptor. Imidazobenzodiazepines as potent cholecystokinin type B receptor antagonistsM G Bock, R M DiPardo, R C Newton, et al.
Biochemical Society Transactions|December 1, 1984
Renin inhibitors containing 2-substituted statineD F Veber, M G Bock, S F Brady, et al.
Journal of Medicinal Chemistry|March 18, 1994
Second-generation benzodiazepine CCK-B antagonists. Development of subnanomolar analogs with selectivity and water solubilityM G Bock, R M DiPardo, E C Mellin, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1991
Antagonism of oxytocin in rats and pregnant rhesus monkeys by the novel cyclic hexapeptides, L-366,682 and L-366,948B V Clineschmidt, D J Pettibone, D R Reiss, et al.
Journal of Medicinal Chemistry|October 16, 1992
Development of a novel class of cyclic hexapeptide oxytocin antagonists based on a natural productP D Williams, M G Bock, R D Tung, et al.
Journal of Medicinal Chemistry|July 1, 1987
Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonistsB E Evans, K E Rittle, M G Bock, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 22, 2024
Target Cell Activation of a Structurally Novel NOD-Like Receptor Pyrin Domain-Containing Protein 3 Inhibitor NT-0796 Enhances PotencyPamela Smolak, MyTrang Nguyen, Christine Diamond, et al.
Pageof 21